NRP1 and neoplasm: A growing collection of literature have shown that increased expression of NRP1 correlates with tumor progression and poor prognosis in hematologic malignancies, such as acute leukemia5–7 and various solid tumors, including pancreatic cancer8 and lung cancer9,10.